Significant Reduction in Pathogenic Gut Bacteria Lowers Potential for Infection Risk in Infants Fed B. infantis EVC001

Evolve BioSystems, Inc. ( announced publication of a study showing that two weeks of supplementation with Bifidobacterium longum subsp. infantis EVC001 (B. infantis EVC001, currently available to consumers as Evivo® baby probiotic) in breastfed infants led to an 85 percent reduction in virulence factor genes, the tools which enable pathogens to thrive and cause infection in humans.

Read More
Tracy Shafizadeh